- Underlying: MRNA
- View: Cautiously Bullish (Expectation of continued momentum towards $57-$60, but with potential for consolidation/pullback after a sharp rally. RSI near overbought suggests limited near-term upside).
- Strategy Type: Bullish Debit Spread
- Option Contract Portfolio:
- Buy 1x MRNA 2026-05-15 $55.00 Call (Mid Price: ~$2.75)
- Sell 1x MRNA 2026-05-15 $60.00 Call (Mid Price: ~$1.46)
- Max Gain & Loss: Max Gain = $2.79 per spread ($5.00 spread width - $2.21 debit). Max Loss = $2.21 per spread (initial debit).
- Initial Cost/Credit: Net Debit of ~$2.21 per spread.
- Greek Exposure (Simulated):
- Delta: +0.35 (Moderate positive directional exposure)
- Theta: -0.02 (Slight negative time decay, but mitigated by short call)
- Vega: -0.05 (Slight negative exposure to IV; benefits from IV contraction)
- Gamma: +0.05 (Moderate sensitivity to price acceleration)
- Rho: +0.01 (Minimal interest rate sensitivity)
- Rationale: This strategy aligns with a "cautiously bullish" view. The bull call spread offers defined risk and lower cost than a naked long call, which is prudent given the elevated IV (77.14%) and near-overbought RSI. It targets the $57-$60 resistance zone for maximum profit. The short $60 call helps finance the long call, reducing the net debit and providing a positive Theta profile relative to a long call alone. The strategy has a positive Delta for upside capture, a manageable negative Vega (beneficial if the post-earnings IV crush continues), and limited Gamma risk.
- Time Frame: Short-Term (1 week to expiry).
๐ Been eyeing Tiger merch but short on Tiger Coins? Now's your chance.
๐ Weโve selected 4 high-demand items across practial, lifestyle, and learning, now with a lower redemption threshold!
Hot Merch Returns ยท Up to 43% Off
Comments